What happens when a course of TMS, Spravato or ketamine ends, and how we help you keep the benefit.
From the end of a course to staying well
Part 1 of 7
A standard TMS course is 36 treatments.
TMS for depression is usually given 5 days a week for 6 weeks. Then it tapers: twice a week for 3 more weeks.
That makes 36 treatments over about 9 weeks. We adjust the plan when a person needs something different.
The evidence
FDA labeling / guidelines
FDA-cleared courses of TMS for depression deliver daily sessions for about 6 weeks, commonly followed by a taper. The total and the taper are individualized in practice.
When the course ends and you are doing well, treatment pauses. We see you about 1 month later to check that the benefit is holding.
Many people keep their benefit. If you are still well, the next visit is a couple of months later, and then every few months.
You never have to wait for a scheduled visit. If you start to slip, call us and we will see you sooner.
The evidence
Human evidence
In a meta-analysis of 19 studies, 66.5% of people who responded to a TMS course still met response criteria at 3 months, 52.9% at 6 months and 46.3% at 12 months. The authors concluded that maintenance treatment may improve durability.
Some people stay well with occasional TMS sessions after the course. This is called maintenance TMS.
It might be once or twice a week, sometimes three times, sometimes every other week. We look for the lowest frequency that keeps you well.
Insurance rarely covers maintenance TMS. A few plans do, and sometimes it has to be requested. We will tell you what your plan says before you decide.
The evidence
Evidence mixed
Studies of maintenance TMS use varied schedules and most are small or uncontrolled. The durability meta-analysis found that maintenance treatment was associated with better sustained response. There is no single established maintenance schedule.
The first job is to lift the depression. With Spravato that is usually two treatments a week for 4 weeks. This is called the induction course.
Ketamine by infusion or injection usually starts with a similar course.
The evidence
FDA labeling / guidelines
The Spravato label specifies twice-weekly dosing in weeks 1 to 4, once weekly in weeks 5 to 8, and weekly or every 2 weeks from week 9. Ketamine is used off-label, and its schedules are less standardized.
After induction, most people need maintenance treatments to keep the benefit. That is usually once a week or every other week, on an ongoing basis.
Without maintenance, the benefit can wear off after a few weeks. That does not mean you end up worse than you started. It means the underlying depression can show itself again.
The evidence
Human evidence
In the SUSTAIN-1 trial, 297 patients who were stable on Spravato plus an antidepressant either continued Spravato or switched to a placebo spray. Continuing reduced the risk of relapse by 51% among patients in stable remission and by 70% among stable responders.
Blood pressure medicine does not cure high blood pressure. It controls it for as long as you take it. Lifestyle changes help too.
Depression is similar. TMS, Spravato and ketamine can bring you out of an episode, but they do not usually cure the underlying condition. Depression tends to come back, so ongoing care and attention are part of treatment.
Lowering stress, sleeping well, staying active and staying connected can make another episode less likely.
The evidence
Well established
Depression is a highly recurrent illness. At least 50% of people who recover from a first episode have one or more further episodes, and about 80% of those with two episodes have another.
We follow you over time. If things begin to slip, we are here, and the sooner we know, the easier it is to help.
Call us if your sleep, energy or interest in things starts to change, or if someone close to you notices a change.
The evidence
Well established
Residual symptoms after treatment and a history of prior episodes are among the strongest predictors of relapse, which is the reason for scheduled follow-up and early re-treatment.